DalsnaFinance › IPOs › Oaktree Acquisition Corp. III Life Sciences IPO
Oaktree Acquisition Corp. III Life Sciences completed its initial public offering on NASDAQ on October 24, 2024, pricing at $10.00 a share.
| Ticker | OACCU |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 24, 2024 |
| Offering price | $10.00 |
| Shares offered | 17,500,000 |
| Total raised | $175M |
Oaktree Acquisition Corp. III Life Sciences sold 17,500,000 shares at $10.00 each on NASDAQ. Multiplied out, that is $175 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $175 million total recorded for the deal.
Measured by money raised, Oaktree Acquisition Corp. III Life Sciences was tied for the 252nd largest (level with 10 other deals) of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is tied for the 182nd largest (level with 9 other listings).
October 2024 saw 18 completed IPOs in the site's data; by amount raised, Oaktree Acquisition Corp. III Life Sciences was the 11th largest of the 18 deals with a recorded size.
Its $10.00 offer price was tied for the 146th highest (level with 259 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Source: SEC EDGAR filings for Oaktree Acquisition Corp. III Life Sciences. This page is general information, not investment advice.